Overview

Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The study will evaluate the safety and efficacy of the intravitreal dexamethasone implant in the study eye of vitrectomized subjects with diabetic macular edema. Subjects will be followed for 26 weeks.
Phase:
Phase 2
Details
Lead Sponsor:
Allergan
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate